The ongoing 2026 Ebola outbreak in the Democratic Republic of the Congo, declared in mid-May and driven by the Bundibugyo strain, remains the dominant factor shaping market views on affected countries. Rapid early growth produced over 7,600 confirmed cases and roughly 3,700 deaths across seven provinces by mid-September, with limited spillover into Uganda (around 20 cases) and one imported case in France. Conflict, population movement, and weak surveillance in eastern DRC have fueled cross-border risks, while recent modest declines in daily cases and improving contact tracing suggest containment momentum may limit further international spread before year-end. Traders are watching September–October surveillance updates and any new imported detections for shifts in implied probabilities on additional countries.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertWhich countries will have an Ebola case in 2026?
Which countries will have an Ebola case in 2026?
$39,277 Vol.
31. Dez. 2026
South Sudan
43%
Rwanda
18%
Burundi
38%
United States
20%
Canada
27%
Kenya
23%
India
43%
Republic of the Congo
22%
Nigeria
50%
Ethiopia
52%
Somalia
35%
China
14%
$39,277 Vol.
South Sudan
$4,406 Vol.
43%
Rwanda
$2,216 Vol.
18%
Burundi
$229 Vol.
38%
United States
$10,886 Vol.
20%
Canada
$2,307 Vol.
27%
Kenya
$237 Vol.
23%
India
$737 Vol.
43%
Republic of the Congo
$12,408 Vol.
22%
Nigeria
$25 Vol.
50%
Ethiopia
$107 Vol.
52%
Somalia
$129 Vol.
35%
China
$3,635 Vol.
14%
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing 2026 Ebola outbreak in the Democratic Republic of the Congo, declared in mid-May and driven by the Bundibugyo strain, remains the dominant factor shaping market views on affected countries. Rapid early growth produced over 7,600 confirmed cases and roughly 3,700 deaths across seven provinces by mid-September, with limited spillover into Uganda (around 20 cases) and one imported case in France. Conflict, population movement, and weak surveillance in eastern DRC have fueled cross-border risks, while recent modest declines in daily cases and improving contact tracing suggest containment momentum may limit further international spread before year-end. Traders are watching September–October surveillance updates and any new imported detections for shifts in implied probabilities on additional countries.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Markt eröffnet: May 22, 2026, 12:35 PM ET
Volumen
$39,277Enddatum
1. Jan. 2027Markt eröffnet
May 22, 2026, 12:35 PM ETAbwickler
0x65070BE91...This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing 2026 Ebola outbreak in the Democratic Republic of the Congo, declared in mid-May and driven by the Bundibugyo strain, remains the dominant factor shaping market views on affected countries. Rapid early growth produced over 7,600 confirmed cases and roughly 3,700 deaths across seven provinces by mid-September, with limited spillover into Uganda (around 20 cases) and one imported case in France. Conflict, population movement, and weak surveillance in eastern DRC have fueled cross-border risks, while recent modest declines in daily cases and improving contact tracing suggest containment momentum may limit further international spread before year-end. Traders are watching September–October surveillance updates and any new imported detections for shifts in implied probabilities on additional countries.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volumen
$39,277Enddatum
1. Jan. 2027Markt eröffnet
May 22, 2026, 12:35 PM ETAbwickler
0x65070BE91...The ongoing 2026 Ebola outbreak in the Democratic Republic of the Congo, declared in mid-May and driven by the Bundibugyo strain, remains the dominant factor shaping market views on affected countries. Rapid early growth produced over 7,600 confirmed cases and roughly 3,700 deaths across seven provinces by mid-September, with limited spillover into Uganda (around 20 cases) and one imported case in France. Conflict, population movement, and weak surveillance in eastern DRC have fueled cross-border risks, while recent modest declines in daily cases and improving contact tracing suggest containment momentum may limit further international spread before year-end. Traders are watching September–October surveillance updates and any new imported detections for shifts in implied probabilities on additional countries.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen